144 related articles for article (PubMed ID: 15140289)
1. Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy.
Chen C; Orel SG; Harris E; Schnall MD; Czerniecki BJ; Solin LJ
Clin Breast Cancer; 2004 Apr; 5(1):72-7. PubMed ID: 15140289
[TBL] [Abstract][Full Text] [Related]
2. Breast conservation treatment for patients presenting with axillary lymphadenopathy from presumed primary breast cancer: the role of breast magnetic resonance imaging for staging.
Chen C; Orel SG; Schnall MD; Harris E; Solin LJ
Clin Breast Cancer; 2002 Aug; 3(3):219-22. PubMed ID: 12196282
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy.
Mehta K; Haffty BG
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):679-85. PubMed ID: 8690633
[TBL] [Abstract][Full Text] [Related]
4. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
Wang X; Zhao Y; Cao X
Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
[TBL] [Abstract][Full Text] [Related]
6. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
7. A patient with occult breast cancer presenting with an axillary lymph node metastasis and a synchronous contralateral breast cancer.
Yirmibeşoğlu E; Tekin E; Memiş L; Yamaç D; Taneri F; Erkal HS
Breast; 2005 Apr; 14(2):157-62. PubMed ID: 15767187
[TBL] [Abstract][Full Text] [Related]
8. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin.
McMahon K; Medoro L; Kennedy D
Australas Radiol; 2005 Oct; 49(5):382-9. PubMed ID: 16174176
[TBL] [Abstract][Full Text] [Related]
9. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
[TBL] [Abstract][Full Text] [Related]
10. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
Kuerer HM; Newman LA; Buzdar AU; Hunt KK; Dhingra K; Buchholz TA; Binkley SM; Ames FC; Feig BW; Ross MI; Hortobagyi GN; Singletary SE
Am J Surg; 1998 Dec; 176(6):502-9. PubMed ID: 9926779
[TBL] [Abstract][Full Text] [Related]
11. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
[TBL] [Abstract][Full Text] [Related]
12. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
Olson JA; Morris EA; Van Zee KJ; Linehan DC; Borgen PI
Ann Surg Oncol; 2000 Jul; 7(6):411-5. PubMed ID: 10894136
[TBL] [Abstract][Full Text] [Related]
14. Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie.
Campana F; Fourquet A; Ashby MA; Sastre X; Jullien D; Schlienger P; Labib A; Vilcoq JR
Radiother Oncol; 1989 Aug; 15(4):321-5. PubMed ID: 2552505
[TBL] [Abstract][Full Text] [Related]
15. Occult breast carcinoma presenting with axillary lymph node metastases.
Medina-Franco H; Urist MM
Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of occult breast cancer in 44 cases].
Lu S; Liu H
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):550-2. PubMed ID: 22093638
[TBL] [Abstract][Full Text] [Related]
17. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.
de Bresser J; de Vos B; van der Ent F; Hulsewé K
Eur J Surg Oncol; 2010 Feb; 36(2):114-9. PubMed ID: 19822403
[TBL] [Abstract][Full Text] [Related]
18. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of women presenting with axillary metastases from occult breast carcinoma.
Blanchard DK; Farley DR
World J Surg; 2004 Jun; 28(6):535-9. PubMed ID: 15366740
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
